SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 14.42 |
| Enterprise Value ($M) | 13.38 |
| Book Value ($M) | 5.19 |
| Book Value / Share | 0.28 |
| Price / Book | 2.78 |
| NCAV ($M) | -2.81 |
| NCAV / Share | -0.15 |
| Price / NCAV | -5.13 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.90 |
| Return on Assets (ROA) | -0.84 |
| Return on Equity (ROE) | -3.10 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.64 |
| Current Ratio | 1.02 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 21.29 |
| Assets | 29.28 |
| Liabilities | 24.10 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Empery Asset Management, LP | |||
| 13D/A | Starke Clifford | 19.10 | 30.80 | |
| 13D/A | Vaiman Dany | 5.60 | 52.80 | |
| 13G/A | Global X Management CO LLC | 0.00 | -100.00 | |
| 13G | Rds Private Capital Ii, Lp | 9.79 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 29,665 | 95,583 | 31.04 | |
| 41,170 | 86,621 | 47.53 | |
| 87,903 | 261,059 | 33.67 | |
| 104,494 | 364,158 | 28.69 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| FBIO – Fortress Biotech, Inc. | FBRX – Forte Biosciences, Inc. |
| FENC – Fennec Pharmaceuticals Inc. | FTLF – FitLife Brands, Inc. |
| GALT – Galectin Therapeutics Inc. |
Financial data and stock pages provided by
Fintel.io